ES2181054T3 - Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento. - Google Patents

Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.

Info

Publication number
ES2181054T3
ES2181054T3 ES97953157T ES97953157T ES2181054T3 ES 2181054 T3 ES2181054 T3 ES 2181054T3 ES 97953157 T ES97953157 T ES 97953157T ES 97953157 T ES97953157 T ES 97953157T ES 2181054 T3 ES2181054 T3 ES 2181054T3
Authority
ES
Spain
Prior art keywords
product
protein product
glp
kgf
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97953157T
Other languages
English (en)
Inventor
Catherine L Farrell
Yue-Sheng Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ES2181054T3 publication Critical patent/ES2181054T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

El uso de uno o varios productos proteicos de KGF y uno o varios productos proteicos de GLP-2 para la preparación de un medicamento para incrementar la citoprotección, la proliferación y/o la diferenciación de las células epiteliales en el tracto gastrointestinal de un paciente.
ES97953157T 1996-12-06 1997-12-08 Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento. Expired - Lifetime ES2181054T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3253396P 1996-12-06 1996-12-06
US6207497P 1997-10-15 1997-10-15

Publications (1)

Publication Number Publication Date
ES2181054T3 true ES2181054T3 (es) 2003-02-16

Family

ID=26708564

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97953157T Expired - Lifetime ES2181054T3 (es) 1996-12-06 1997-12-08 Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.

Country Status (10)

Country Link
EP (1) EP1012186B1 (es)
JP (1) JP4091988B2 (es)
AT (1) ATE220689T1 (es)
AU (1) AU5696298A (es)
CA (1) CA2272854C (es)
DE (1) DE69714085T2 (es)
DK (1) DK1012186T3 (es)
ES (1) ES2181054T3 (es)
PT (1) PT1012186E (es)
WO (1) WO1998024813A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
DK0981362T3 (da) * 1997-05-16 2004-03-15 Ontario Inc 1149336 Anvendelse af GLP-2-agonister, der forbedrer funktionen af den øvre mavetarmkanal
US6248725B1 (en) 1999-02-23 2001-06-19 Amgen, Inc. Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
ES2310192T3 (es) 2000-09-18 2009-01-01 Sanos Bioscience A/S Uso de peptidos glp-2.
US7371721B2 (en) 2000-09-18 2008-05-13 Sanos Bioscience A/S Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7186683B2 (en) 2000-09-18 2007-03-06 Sanos Bioscience A/S Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
AU2002233089B2 (en) * 2001-02-16 2005-12-22 Conjuchem Biotechnologies Inc. Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
AU2007214362B2 (en) * 2001-08-21 2009-11-26 Novartis Vaccines And Diagnostics, Inc. KGF polypeptide compositions
US7265089B2 (en) 2001-08-21 2007-09-04 Chiron Corporation KGF polypeptide compositions
AU2005317166B2 (en) * 2004-12-15 2009-09-10 Biovitrum Ab (Publ) Therapeutic formulations of keratinocyte growth factor
JP2016535770A (ja) 2013-11-01 2016-11-17 スフェリウム バイオメッド エス．エル． 治療用及び美容用物質を経皮送達するための封入体
KR102449167B1 (ko) * 2016-05-06 2022-09-28 파세비오 파마수티컬스 인코포레이티드 제어된 지속 방출을 위한 elp 융합 단백질

Also Published As

Publication number Publication date
JP2001510333A (ja) 2001-07-31
AU5696298A (en) 1998-06-29
JP4091988B2 (ja) 2008-05-28
DE69714085D1 (de) 2002-08-22
ATE220689T1 (de) 2002-08-15
WO1998024813A3 (en) 1998-08-06
DE69714085T2 (de) 2002-11-14
PT1012186E (pt) 2002-12-31
CA2272854A1 (en) 1998-06-11
WO1998024813A2 (en) 1998-06-11
CA2272854C (en) 2004-02-10
EP1012186B1 (en) 2002-07-17
DK1012186T3 (da) 2002-11-04
EP1012186A2 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
MX22877A (es) Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye
EP2258402A3 (en) Dried composition
LV12438A (en) Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof
ES2181054T3 (es) Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
AU4926690A (en) Oxidized diphenylheteroalkanes, the preparation and use thereof
HUP9903459A3 (en) Oxa- and tiabicyclo[3.1.0]hexane-carboxylic acids, process for their preparation and pharmaceutical compositions of the same
MX14310A (es) Procedimiento para la preparacion de nuevos agentes antiarritmicos, producto obtenido y preparacion farmaceutica que lo incluye.
MX9701996A (es) Utlizacion de 3-oxo de 2, 4-diamino-pirimidina o una de sus sales en el tratamiento de desordenes dela maduracion y de la estructuracion del colageno.
DK0443848T3 (da) Nyt antiulcermiddel
MX17107A (es) Procedimiento para la preparacion de tiazolo-(1,5)-benzodiazepinas y producto obtenido
AU8235291A (en) Lyophilized native collagen sheets comprising cosmetic formulations for the treatment of couperose
ES2054942T3 (es) Procedimiento para la determinacion de fructuosaminas.
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
AU1939697A (en) Physiologically active substances tkr1785's, process for the preparation thereof, and microbe
PT741746E (pt) Compostos sinteticos relacionados com a timosina alfa1 e novos metodos para a sua sintese
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
DE59610341D1 (de) Verfahren zur Herstellung von 2,4,6-Trichlorpyrimidin
BR9505394A (pt) Composição para pinturas artísticas corporal no corpo humano
FI970269A0 (fi) 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö
MX14871A (es) Procedimiento para la preparacion de pirroles substituidos y producto obtenido.
SI1012186T1 (en) Use of a kgf protein product(s) and a glp-2 protein product(s) for the preparation of a medicament
MX20574A (es) Procedimiento para la preparacion de derivados de la sacarina y producto obtenido.